These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The soluble form of LR11 protein is a regulator of hypoxia-induced, urokinase-type plasminogen activator receptor (uPAR)-mediated adhesion of immature hematological cells. Nishii K, Nakaseko C, Jiang M, Shimizu N, Takeuchi M, Schneider WJ, Bujo H. J Biol Chem; 2013 Apr 26; 288(17):11877-86. PubMed ID: 23486467 [Abstract] [Full Text] [Related]
10. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation. Zhang L, Wang Y, Wu G, Rao L, Wei Y, Yue H, Yuan T, Yang P, Xiong F, Zhang S, Zhou Q, Chen Z, Li J, Mo BW, Zhang H, Xiong W, Wang CY. Cell Prolif; 2020 Feb 26; 53(2):e12742. PubMed ID: 31943454 [Abstract] [Full Text] [Related]
15. Pulmonary artery smooth muscle cell endothelin-1 expression modulates the pulmonary vascular response to chronic hypoxia. Kim FY, Barnes EA, Ying L, Chen C, Lee L, Alvira CM, Cornfield DN. Am J Physiol Lung Cell Mol Physiol; 2015 Feb 15; 308(4):L368-77. PubMed ID: 25399435 [Abstract] [Full Text] [Related]
16. Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha. Nemenoff RA, Simpson PA, Furgeson SB, Kaplan-Albuquerque N, Crossno J, Garl PJ, Cooper J, Weiser-Evans MC. Circ Res; 2008 May 09; 102(9):1036-45. PubMed ID: 18340011 [Abstract] [Full Text] [Related]
17. HMGB2 Release Promotes Pulmonary Hypertension and Predicts Severity and Mortality of Patients With Pulmonary Arterial Hypertension. Kong D, Liu J, Lu J, Zeng C, Chen H, Duan Z, Yu K, Zheng X, Zou P, Zhou L, Lv Y, Zeng Q, Lu L, Li J, He Y. Arterioscler Thromb Vasc Biol; 2024 Jun 09; 44(6):e172-e195. PubMed ID: 38572649 [Abstract] [Full Text] [Related]